RBM9 inhibitors belong to a class of chemical compounds designed to target a specific biological molecule known as RNA Binding Motif Protein 9 (RBM9). These inhibitors are molecular agents developed for their potential to modulate the activity of RBM9 within cellular processes. RBM9 itself is a protein that plays a significant role in RNA metabolism and processing, particularly in post-transcriptional events. By inhibiting RBM9, these chemical compounds can influence various aspects of RNA regulation and gene expression.
RBM9 inhibitors involves their ability to bind to the RBM9 protein, disrupting its normal functions. This interaction can lead to altered RNA splicing, mRNA stability, or protein translation, depending on the specific role of RBM9 within a cellular context. By interfering with these processes, RBM9 inhibitors can impact the overall gene expression patterns and cellular responses, potentially resulting in downstream effects on cellular physiology. Researchers have been exploring the use of RBM9 inhibitors as valuable tools for studying the intricacies of RNA biology and the regulation of gene expression, providing insights into fundamental biological processes.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $290.00 $5572.00 $10815.00 $25000.00 $65000.00 $2781.00 | 63 | |
Binds to the SF3b complex of the spliceosome, potentially impacting pre-mRNA splicing and indirectly affecting RBM9 function. | ||||||
Madrasin | 374913-63-0 | sc-507563 | 100 mg | $750.00 | ||
Interferes with splicesome activity, possibly altering RBM9 pre-mRNA processing. | ||||||
PD 166866 | 192705-79-6 | sc-208154 | 5 mg | $300.00 | 1 | |
Engages with RBM39, a component of the splicing machinery, potentially affecting the splicing of RBM9. | ||||||